FDA Clears Siemens’ SOMATOM Definition AS Open for Radiation Therapy

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Endo Announces Peyronie’s Disease Presentation at...

Endo, a wholly-owned subsidiary of Mallinckrodt plc, announced today...

Leadership at NHS Hospitals in Leeds...

A watchdog has gone on to say that the...

Developing Dr. CaBot, A Medical Education...

Harvard Medical School researchers are developing Dr. CaBot as...

UK & U.S. Regulators Partner for...

The medicines regulator of the UK has announced plans...
Siemens Healthcare has announced that its SOMATOM® Definition AS Open – a high-end computed tomography (CT) system that can be dedicated to efficiently cover the needs of both diagnostic radiology and radiation therapy – has been cleared by the U.S. Food and Drug Administration (FDA). Delivering excellent image quality at low dose, the Definition AS Open enables exact contouring for planning while minimizing exposure to the patient. The scanner also has several unique service offerings and is upgradeable for multipurpose use.

Wolfgang Rueger, PhD, vice president, Radiation Oncology, Siemens Healthcare said, Siemens is pleased to offer the SOMATOM Definition AS Open, which introduces state-of-the-art CT imaging to radiation therapy planning. Its ease of use and integration, as well as its ability to deliver excellent or high image quality at low dose, will increase the quality and efficiency of patient care, as well as open the door to new clinical and economic possibilities.

Latest stories

Related stories

Developing Dr. CaBot, A Medical Education Tool That Reasons

Harvard Medical School researchers are developing Dr. CaBot as...

UK & U.S. Regulators Partner for Medtech Regulatory Reforms

The medicines regulator of the UK has announced plans...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »